Eleven associations representing the European and British life science industry, including the Association of the British Pharmaceutical Industry (ABPI), have today launched a joint policy document on the potential impact of the United Kingdom’s exit from the European Union.
23 Mar 2018
The Association of the British Pharmaceutical Industry (ABPI) - representing leading global pharmaceutical businesses in the UK - have welcomed the EU Council's agreement to progress Brexit negotiations to the next phase and the EU Council's approval of a transition period.
02 Mar 2018
The ABPI has responded to the Prime Minister's ‘Road to Brexit’ speech today at Mansion House.
16 Jan 2018
As the MHRA publishes an update to pharmaceutical companies on preparing for Brexit, the ABPI reaffirms the importance of patient and public health in negotiations.
28 Jan 2018
Making sure patients continue to get the medicines they need is of upmost importance as we negotiate the UK’s withdrawal from the EU.
21 Mar 2018
Responding to a new House of Commons Health and Social Care Select Committee report ‘Brexit – Medicines, Medical Devices and Substances of Human Origin’, the trade associations representing the UK's pharmaceutical and biotech industries have issued a joint response backing the Committee's recommendations.
18 Apr 2018
Last week, the EMA announced it has completed the reallocation of the medicines for which the UK's national regulator - the MHRA - is currently rapporteur or co-rapporteur appointed by the scientific committees to coordinate the evaluation of a medicine.
19 Apr 2018
UK Marketing Authorisation Holders urged to register with SecurMed UK
12 Dec 2017
To coincide with today’s House of Commons Health Select Committee on ‘Brexit: the regulation of medicines, medical devices and substances of human origin’, the Association of the British Pharmaceutical Industry (ABPI) and the BioIndustry Association (BIA) have published new research on the public health implications of Brexit.
06 Sep 2017
The ABPI and the BIA have welcomed the UK Government’s latest Brexit position paper on ‘Collaboration on science and innovation’.
21 Aug 2017
The Association of the British Pharmaceutical Industry (ABPI) and the BioIndustry Association (BIA) have welcomed the publication of "Continuity in the availability of goods for the EU and the UK", published today by the UK Government's Department for Exiting the European Union.